Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma

被引:13
作者
Cambruzzi, E [1 ]
Zettler, CG [1 ]
Alexandre, COP [1 ]
机构
[1] Fundacao Fac Fed Ciencias Med Porto Alegre, Porto Alegre, RS, Brazil
关键词
endocervical adenocarcinoma; bcl-2; Ki-67; p53; HPV;
D O I
10.1007/BF02893378
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To estimate the association between human papillomavirus (HPV) status and the expression of p53, Ki67 and bcl-2 in cases of endocervical adenocarcinoma, and the relation with squamous intraepithelial lesions (SIL) and age, 229 cases were selected, treated between 1995 and 2003 in the Hospital Nossa Senhora da Conceicao. All samples were evaluated by polymerase chain reaction to determine HPV status. Immunohistochemical technique was used to investigate the expression of p53, Ki-67 and bcl-2. The joint occurrence of endocervical adenocarcinoma and SIL were estimated too. In the 229 evaluated cases, 182 cases (79.48%) were associated with the presence of the HPV. The most common types were HPV18 ( 93 cases - 51.09%) and HPV16 ( 62 cases - 34.06%). Expression of Ki-67 (p = 0.009) and the presence of SIL (p = 0.018) were associated to HPV infection. Expression of p53 (p = 0.647) and bcl-2 (p = 0.671) were not related to HPV status. The mean age of the patients was 53.2 years, without clear correlation between age group and HPV (p = 0.095). The presence of HPV, especially type 18 in endocervical adenocarcinoma suggests that this agent can be an important cofactor in the development and progression of glandular neoplasms of the uterine cervix. The joint occurrence of endocervical adenocarcinoma and SIL may support this hypothesis. HPV may promote an increased proliferation index in endocervical adenocarcinoma, shown by the expression of Ki-67.
引用
收藏
页码:114 / 120
页数:7
相关论文
共 54 条
[1]  
Alfsen GC, 2000, CANCER, V89, P1291, DOI 10.1002/1097-0142(20000915)89:6<1291::AID-CNCR14>3.3.CO
[2]  
2-F
[3]   Apoptosis, proliferation, and expression of p53 and bcl-2 in endocervical glandular intraepithelial lesions and invasive endocervical adenocarcinoma [J].
Ali-Fehmi, R ;
Qureshi, F ;
Lawrence, WD ;
Jacques, SM .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2004, 23 (01) :1-6
[4]  
ALSADER MH, 1996, J PATHOL, V178, P50
[5]   Adenocarcinoma of the uterine cervix:: the presence of human papillomavirus and the method of detection [J].
Andersson, S ;
Larson, B ;
Hjerpe, A ;
Silfverswärd, C ;
Sällström, J ;
Wilander, E ;
Rylander, E .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (10) :960-965
[6]   The role of human papillomavirus in cervical adenocarcinoma carcinogenesis [J].
Andersson, S ;
Rylander, E ;
Larsson, B ;
Strand, A ;
Silfversvärd, C ;
Wilander, E .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (02) :246-250
[7]   Novel cancer therapy by reactivation of the p53 apoptosis pathway [J].
Bykov, VJN ;
Wiman, KG .
ANNALS OF MEDICINE, 2003, 35 (07) :458-465
[8]   Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia [J].
Cameron, RI ;
Maxwell, P ;
Jenkins, D ;
McCluggage, WG .
HISTOPATHOLOGY, 2002, 41 (04) :313-321
[9]   Apotosis-related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix [J].
Cheung, TH ;
Chung, TKH ;
Lo, KWK ;
Yu, MY ;
Krajewski, S ;
Reed, JC ;
Wong, YF .
GYNECOLOGIC ONCOLOGY, 2002, 86 (01) :14-18
[10]   G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value [J].
Cho, NH ;
Lim, SY ;
Kim, YT ;
Kim, D ;
Kim, YS ;
Kim, JW .
GYNECOLOGIC ONCOLOGY, 2003, 90 (01) :15-22